BlackRock’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$341M Buy
7,260,644
+1,014,573
+16% +$47.7M 0.01% 1273
2025
Q1
$276M Buy
6,246,071
+285,712
+5% +$12.6M 0.01% 1393
2024
Q4
$215M Buy
5,960,359
+18,562
+0.3% +$671K ﹤0.01% 1624
2024
Q3
$190M Buy
5,941,797
+322,537
+6% +$10.3M ﹤0.01% 1679
2024
Q2
$212M Buy
5,619,260
+180,403
+3% +$6.8M ﹤0.01% 1567
2024
Q1
$268M Buy
5,438,857
+56,673
+1% +$2.79M 0.01% 1443
2023
Q4
$196M Buy
5,382,184
+956,452
+22% +$34.9M 0.01% 1646
2023
Q3
$102M Buy
4,425,732
+166,341
+4% +$3.85M ﹤0.01% 1955
2023
Q2
$112M Buy
4,259,391
+1,015,359
+31% +$26.6M ﹤0.01% 1954
2023
Q1
$83.5M Sell
3,244,032
-80,706
-2% -$2.08M ﹤0.01% 2100
2022
Q4
$86.5M Buy
3,324,738
+503,394
+18% +$13.1M ﹤0.01% 2079
2022
Q3
$80.5M Buy
2,821,344
+201,887
+8% +$5.76M ﹤0.01% 2090
2022
Q2
$64.5M Buy
2,619,457
+316,178
+14% +$7.78M ﹤0.01% 2290
2022
Q1
$130M Sell
2,303,279
-58,373
-2% -$3.29M ﹤0.01% 1943
2021
Q4
$146M Sell
2,361,652
-79,526
-3% -$4.93M ﹤0.01% 1948
2021
Q3
$155M Sell
2,441,178
-45,145
-2% -$2.86M ﹤0.01% 1896
2021
Q2
$205M Buy
2,486,323
+216,785
+10% +$17.9M 0.01% 1730
2021
Q1
$167M Buy
2,269,538
+23,395
+1% +$1.72M ﹤0.01% 1836
2020
Q4
$163M Buy
2,246,143
+911,500
+68% +$66.1M 0.01% 1750
2020
Q3
$63.6M Buy
1,334,643
+123,973
+10% +$5.91M ﹤0.01% 2115
2020
Q2
$50.8M Buy
1,210,670
+551,575
+84% +$23.2M ﹤0.01% 2215
2020
Q1
$17.8M Buy
659,095
+18,134
+3% +$490K ﹤0.01% 2631
2019
Q4
$24.7M Buy
640,961
+537,382
+519% +$20.7M ﹤0.01% 2734
2019
Q3
$2.25M Buy
+103,579
New +$2.25M ﹤0.01% 3664